Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
New standards launched to improve public involvement in research
New national standards to improve the quality of public involvement in research.
Old sales techniques are history and sales forces must adapt
Despite all the rhetoric about multichannel marketing, patient centricity and the inexorable rise of digital, the most effective sales channel is still standing ‘two...
How to concentrate sales efforts in the right place
Right place, right time In part two of a series looking at the effective use of data, Dr Graham Leask addresses how to concentrate sales...
Sales force awakens to boost ROI
Sales force awakens
Karen Bell, Director of Business Development at Ashfield Commercial and Clinical UK, on maximising return on investment. Sales force effectiveness (SFE) is about...
The rise of digital marketing: pharma and social media
Social media is a prerequisite for most businesses, but how has the historically reticent pharma industry been adapting?
Graeme Smith
Managing Partner, Fortis Pharma Consulting
The highly–regulated...
Marketing Focus: the shift from treatment to prevention
Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene
Dr Graham Leask and Stewart Adkins...
Marketing Focus: helping modern marketeers to thrive
PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...
Latest articles
Servier and UCL collaborate on immune-inflammatory disease treatments
Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...
Forendo and Novartis partner on novel chronic liver disease treatments
Forendo and Novartis are to partner on novel chronic liver disease treatments. Forendo Pharma, a clinical stage drug development company focusing on novel treatments...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Popular articles
Living well with HIV and AIDS around the world
1st December is World AIDS Day which raises awareness of HIV and AIDS around the world. There have been huge leaps in the treatment...
AstraZeneca and MSD’s Lynparza™ now available in Scotland
AstraZeneca and MSD's Lynparza™ is now available in Scotland as the companies announce that olaparib monotherapy is now accepted for use by the Scottish...
How are LifeArc collaborating to advance research and science for patient benefit?
Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Merging CCGs to align commissioning
Julie Das-Thompson, Head of Policy and Delivery at NHS Clinical Commissioners, researches how 2020 will see the merging of at least 20 clinical commissioning...